Home LiteratureArticle Details
PMID: 3267021 Published · ppublish English Journal Article

Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.

The Journal of physiology ·Vol. 403 ·1988-09-00 ·Pages 511-23

Lightman SL, Young WS

Abstract

1. Rats underwent either: (1) acute or chronic morphine or naloxone administration; (2) simple morphine withdrawal or naloxone-precipitated withdrawal in morphine-dependent animals; or (3) stress from I.P. administration of hypertonic saline. 2. Quantitative in situ hybridization histochemistry was performed using synthetic oligonucleotide probes for corticotrophin-releasing factor (CRF), vasopressin, pro-opiomelanocortin (POMC), dynorphin, enkephalin and oxytocin mRNAs. The paraventricular and supraoptic nuclei were examined in all studies and the arcuate nucleus and pituitary gland in the acute withdrawal study. 3. Neither acute nor chronic morphine administration altered either (a) hypothalamic parvocellular or magnocellular CRF mRNA, or (b) anterior pituitary or pars intermedia POMC mRNA. 4. Naloxone-precipitated morphine withdrawal resulted in a marked increase in parvocellular (but not magnocellular) CRF mRNA within 4 h and levels remained elevated through 24 h. There was no change in arcuate nucleus or pars intermedia POMC mRNA, but in the anterior pituitary there was a delayed increase, significant at 24 h. 5. Simple morphine withdrawal without the use of naloxone did not result in any change in CRF mRNA but there were increases in magnocellular vasopressin and dynorphin mRNA, presumably related to decreased water intake. 6. Intraperitoneal hypertonic saline stress also resulted in a marked accumulation of both parvocellular CRF and vasopressin mRNA without any concomitant change in magnocellular vasopressin mRNA. Increased translation of CRF mRNA was also evidenced by increased immunoreactive CRF detected by immunocytochemistry.

MeSH Terms
Animals Corticotropin-Releasing Hormone/genetics Male Narcotics/pharmacology Paraventricular Hypothalamic Nucleus/analysis Pituitary Gland/analysis Pro-Opiomelanocortin/genetics RNA, Messenger/analysis Rats Rats, Inbred Strains Stress, Physiological/physiopathology Substance Withdrawal Syndrome/physiopathology Vasopressins/genetics
Chemicals
Narcotics RNA, Messenger Vasopressins Pro-Opiomelanocortin Corticotropin-Releasing Hormone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lightman S L
Laboratory of Cell Biology, National Institute of Mental Health, Bethesda, MD 20892.
Young W S
References (35)
35 references, click to expand
  1. Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone.
    J Endocrinol. 1988 Apr;117(1):27-34 PMID: 3356957
  2. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia.
    Endocrinology. 1985 Jul;117(1):323-9 PMID: 2988921
  3. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.
    Endocrinology. 1971 Jan;88(1):3-15 PMID: 4320769
  4. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Neuroendocrinology. 1984 May;38(5):411-7 PMID: 6328347
  5. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.
    Proc Natl Acad Sci U S A. 1984 Mar;81(6):1883-7 PMID: 6369332
  6. Oral ingestion of narcotic analgesics by rats.
    J Pharmacol Exp Ther. 1976 Feb;196(2):269-79 PMID: 943520
  7. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.
    Neuroendocrinology. 1983;36(3):165-86 PMID: 6601247
  8. Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles.
    Nature. 1985 Sep 19-25;317(6034):248-50 PMID: 3900740
  9. Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids.
    Endocrinology. 1984 Jan;114(1):164-9 PMID: 6317342
  10. Corticotropin-releasing factor. Proceedings of a conference, February 20-24, 1984 sponsored by the Kroc Foundation.
    Fed Proc. 1985 Jan;44(1 Pt 2):145-263 PMID: 3871407
  11. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor.
    Endocr Rev. 1986 Nov;7(4):351-78 PMID: 3023041
  12. Studies on the mechanism of pituitary-adrenal activation by morphine.
    Br J Pharmacol Chemother. 1955 Jun;10(2):260-4 PMID: 14389670
  13. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Endocrinology. 1985 Oct;117(4):1293-9 PMID: 3161722
  14. Preferences for morphine in rats: validation of an experimental model of dependence.
    Psychopharmacologia. 1970;17(2):137-50 PMID: 5462744
  15. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal.
    Nature. 1987 Aug 13-19;328(6131):643-5 PMID: 3614366
  16. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats.
    Endocrinology. 1985 Oct;117(4):1314-20 PMID: 2992910
  17. Corticotrophin releasing factor may be modulated vasopressin.
    Nature. 1979 Mar 29;278(5703):463-4 PMID: 313009
  18. Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment.
    J Physiol. 1988 Feb;396:297-317 PMID: 2900890
  19. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats.
    Neurosci Lett. 1986 Oct 8;70(2):198-203 PMID: 3490635
  20. Vasopressin activation of phosphatidylinositol metabolism in rat anterior pituitary in vitro and its modification by changes in the hypothalamo-pituitary-adrenal axis.
    Neuroendocrinology. 1987 Mar;45(3):212-8 PMID: 3561697
  21. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract.
    Neuroendocrinology. 1983 Jun;36(6):415-23 PMID: 6348576
  22. Intragranular colocalization of arginine vasopressin and methionine-enkephalin-octapeptide in CRF-axons in the rat median eminence.
    Cell Tissue Res. 1987 Sep;249(3):497-507 PMID: 3499227
  23. Measurement of hypothalamic corticotropin-releasing factors in hypophyseal portal blood.
    Fed Proc. 1985 Jan;44(1 Pt 2):203-6 PMID: 2981742
  24. Corticotropin-releasing factor differentially regulates proopiomelanocortin messenger ribonucleic acid levels in anterior as compared to intermediate pituitary lobes of rats.
    Biochem Biophys Res Commun. 1984 Oct 30;124(2):407-15 PMID: 6093800
  25. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin.
    Nature. 1982 Sep 23;299(5881):355-7 PMID: 6287293
  26. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9827-31 PMID: 2432603
  27. Inhibition of corticotropin release during hypothermia: the role of corticotropin-releasing factor, vasopressin, and oxytocin.
    Endocrinology. 1985 Feb;116(2):723-7 PMID: 2981677
  28. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy.
    Proc Natl Acad Sci U S A. 1984 Mar;81(6):1854-8 PMID: 6608732
  29. Pituitary-adrenal activation following intrahypothalamic microinjection of morphine.
    Neuroendocrinology. 1969;4(6):326-32 PMID: 5394282
  30. Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy.
    Nature. 1985 May 2-8;315(6014):59-61 PMID: 3873012
  31. Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Immunohistochemical demonstration in adrenalectomized guinea pigs and rats.
    Neuroendocrinology. 1983 Dec;37(6):467-9 PMID: 6606790
  32. The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
    Endocrinology. 1986 Jun;118(6):2534-9 PMID: 2938937
  33. Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.
    J Physiol. 1987 Dec;394:23-39 PMID: 2895179
  34. Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary.
    Neuroendocrinology. 1986;43(3):277-82 PMID: 2942792
  35. Assay of corticotropin releasing factor.
    Methods Enzymol. 1983;103:565-77 PMID: 6321896
Article Info
Journal
The Journal of physiology
Abbr.
J Physiol
ISSN
0022-3751
Published
1988-09-00
Pages
511-23
Language
English
Region
England
NLM ID
0266262
PMCID
PMC1190725
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]